Issued Patents All Time
Showing 76–100 of 132 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9572836 | Methods for assessing the suitability of transduced T cells for administration | Bruce L. Levine, Michael D. Kalos | 2017-02-21 |
| 9573988 | Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells | Jennifer Brogdon, Saar Gill, Michael D. Kalos, Andreas Loew, John Scholler | 2017-02-21 |
| 9555105 | Artificial antigen presenting cells and uses thereof | James L. Riley, Robert Vonderheide, Nicole Aqui, Megan Davis | 2017-01-31 |
| 9540445 | Compositions and methods for treatment of cancer | Bruce L. Levine, David L. Porter, Michael D. Kalos, Michael C. Milone | 2017-01-10 |
| 9518123 | Compositions and methods for treatment of cancer | Bruce L. Levine, David L. Porter, Michael D. Kalos, Michael C. Milone | 2016-12-13 |
| 9499629 | Use of chimeric antigen receptor-modified T-cells to treat cancer | Bruce L. Levine, David L. Porter, Michael D. Kalos, Michael C. Milone | 2016-11-22 |
| 9481728 | Compositions and methods for treatment of cancer | Bruce L. Levine, David L. Porter, Michael D. Kalos, Michael C. Milone | 2016-11-01 |
| 9464140 | Compositions and methods for treatment of cancer | Bruce L. Levine, David L. Porter, Michael D. Kalos, Michael C. Milone | 2016-10-11 |
| 9453199 | Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool | James L. Riley, Marcela Maus, Anna Kaskel, Robert Vonderheide | 2016-09-27 |
| 9394368 | Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor | Jennifer Brogdon, Laura Alexandra Johnson, Andreas Loew, Marcela Maus, John Scholler +1 more | 2016-07-19 |
| 9365641 | Compositions and methods for targeting stromal cells for the treatment of cancer | Ellen Puré, Liang-Chuan Wang, Steven M. Albelda, John Scholler | 2016-06-14 |
| 9328156 | Use of chimeric antigen receptor-modified T cells to treat cancer | Bruce L. Levine, David L. Porter, Michael D. Kalos, Michael C. Milone | 2016-05-03 |
| 9273282 | Methods for the isolation and expansion of cord blood derived T regulatory cells | Wayne R. Godfrey | 2016-03-01 |
| 9228172 | Inducible regulatory T-cell generation for hematopoietic transplants | James L. Riley, Bruce R. Blazar, Keli Hippen | 2016-01-05 |
| 9187727 | Methods for the isolation and expansion of cord blood derived T regulatory cells | Wayne R. Godfrey | 2015-11-17 |
| 9181526 | Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses | Bruce R. Blazar, Wayne R. Godfrey, Richard G. Carroll, Bruce L. Levine, James L. Riley +1 more | 2015-11-10 |
| 9161971 | Method for treating chronic lymphocytic leukemia (CC) | Bruce L. Levine, Anne Chew, Stephen J. Schuster | 2015-10-20 |
| 9133436 | ICOS critically regulates the expansion and function of inflammatory human Th17 cells | James L. Riley, Chrystal Paulos, Bruce L. Levine | 2015-09-15 |
| 9102760 | Compositions for treatment of cancer | Bruce L. Levine, David L. Porter, Michael D. Kalos, Michael C. Milone | 2015-08-11 |
| 9101584 | Methods for treatment of cancer | Bruce L. Levine, David L. Porter, Michael D. Kalos, Michael C. Milone | 2015-08-11 |
| 9102761 | Compositions for treatment of cancer | Bruce L. Levine, David L. Porter, Michael D. Kalos, Michael C. Milone | 2015-08-11 |
| 8975071 | Compositions for treatment of cancer | Bruce L. Levine, David L. Porter, Michael D. Kalos, Michael C. Milone | 2015-03-10 |
| 8916381 | Methods for treatment of cancer | Bruce L. Levine, David L. Porter, Michael D. Kalos, Michael C. Milone | 2014-12-23 |
| 8911993 | Compositions for treatment of cancer | Bruce L. Levine, David L. Porter, Michael D. Kalos, Michael C. Milone | 2014-12-16 |
| 8906682 | Methods for treatment of cancer | Bruce L. Levine, David L. Porter, Michael D. Kalos, Michael C. Milone | 2014-12-09 |